{"id":"NCT00936884","sponsor":"Bausch Health Americas, Inc.","briefTitle":"Study Evaluating the Efficacy and Safety of Subcutaneous Methylnaltrexone (MOA-728) for the Treatment of Opioid-Induced-Constipation","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, And Parallel-Group Study Of Subcutaneous Methylnaltrexone (MOA-728) For The Treatment Of Opioid-Induced Constipation In Adult Subjects","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-07","primaryCompletion":"2013-11","completion":"2013-11","firstPosted":"2009-07-10","resultsPosted":"2020-01-02","lastUpdate":"2020-01-02"},"enrollment":50,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Constipation"],"interventions":[{"type":"DRUG","name":"Methylnaltrexone","otherNames":["MOA-728","MNTX"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Methylnaltrexone double-blind","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Methylnaltrexone open-label","type":"OTHER"}],"summary":"The primary purpose of this study is to evaluate the safety, efficacy, and tolerability of subcutaneous (injection beneath the skin) MOA-728 versus placebo in adult Asian subjects with opioid-induced constipation associated with advanced illness (ie, a terminal illness such as incurable cancer or other end-stage disease) or chronic nonmalignant pain.","primaryOutcome":{"measure":"The Proportion of Subjects Having a Rescue-free Bowel Movement (RFBM) Within 4 Hours After the First Injection.","timeFrame":"Up to 4 hours after the first injection","effectByArm":[{"arm":"Methylnaltrexone Double-blind","deltaMin":79.2,"sd":null},{"arm":"Placebo","deltaMin":4.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":6,"countries":["South Korea","Taiwan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":25},"commonTop":["Asthenia","Decreased appetite","Ascites","Anemia","Dysuria"]}}